Search Results
                            21 Results for 'Other drug discovery & development'                        
                        
                            PAGE 1 OF 1                        
                    Technology
RNA-Guided DNA Transportation
            UW-Madison researchers have applied transposon technology to CRISPR-mediated gene targeting to create libraries of genetically modified bacteria displaying differentially expressed genes throughout th...            
Learn More
        Learn More
            Jason Peters, Amy Banta | P230410US02
        
    Technology
HIGH THROUGHPUT INFUSION PEPTIDE MAPPING
            UW-Madison researchers have developed a high throughput peptide mapping platform by combining a plate-based sample preparation method with direct injection MS analysis. Protein samples are cleaned, re...            
Learn More
        Learn More
            Joshua Coon, Alexander Hebert | P230059WO01
        
    Technology
Novel Methods for In Vivo Cell Tracking
            Cell therapy is a novel and promising approach to treating diseases such as rheumatoid arthritis, atherosclerosis, acute ischemia, myocardial infarction, diabetes, graft versus host disease and cancer...            
Learn More
        Learn More
            Reinier Hernandez, Anatoly Pinchuk, Liudmila Lambert Lepesevich, Zachary Rosenkrans, Anna Thickens, Nathan Clemons | P230038US02
        
    Technology
ENGINEERED TRYPTOPHAN DECARBOXYLASES AND USES THEREOF FOR SYNTHESIZING TRYPTAMINE ANALOGS
            UW-Madison researchers have identified several tryptophan decarboxylase (TDC) mutations for improving enzymatic activity towards substituted tryptamines. Having identified these mutations, the researc...            
Learn More
        Learn More
            Andrew Buller, Allwin McDonald | P220120US02
        
    Technology
SITE-SELECTIVE DEUTERATION OF AMINO ACIDS THROUGH DUAL PROTEIN CATALYSIS
            UW-Madison researchers have developed a protein-based method for selective deuteration of amino acids. The inventors’ method leverages the aminotransferase DsaD, a PLP-dependent enzyme, and a small ...            
Learn More
        Learn More
            Andrew Buller, Tyler Doyon | P220181US02
        
    Technology
MUTANT ACE2 PROTEINS AND METHODS OF USING SAME
            UW-Madison researchers have identified novel ACE2 mutants having enhanced activity and/or specificity in hydrolyzing angiotensin II. ACE2 (angiotensin converting enzyme 2) is a key metalloprotease of ...            
Learn More
        Learn More
            Philip Romero, Peter Heinzelman | P210188WO01
        
    Technology
A NOVEL STRATEGY ENABLED BY A PHOTO-CLEAVABLE SURFACTANT FOR EXTRACELLULAR VESICLE PROTEOMICS
            Building off of their prior discovery (Photo-Cleavable Surfactants P180335US02), UW-Madison researchers disclose an improved method for exosome proteomics. The method leverages the researchers’ phot...            
Learn More
        Learn More
            Ying Ge, Song Jin, Kyle Brown, Kevin Buck | P220113US02
        
    Technology
            UW-Madison researchers have developed a titin DNA construct (a ‘titin minigene plasmid’) that is useful for identifying agents that modulate the titin size reduction that correlates with age and l...            
Learn More
        Learn More
            Wei Guo, Yanghai Zhang | P230097US01
        
    Technology
METHOD FOR DIFFERENTIATION OF BRAIN MURAL CELLS FROM HUMAN PLURIPOTENT STEM CELLS
            UW-Madison researchers disclose a new method for differentiating brain mural cells – encompassing pericytes and vascular smooth muscle cells – from hPSCs. The inventors used their previously discl...            
Learn More
        Learn More
            Eric Shusta, Benjamin Gastfriend, Sean Palecek | P220005US02
        
    Technology
GENERATION OF NOREPINEPHRINE NEURONS FROM HUMAN STEM CELLS
            Methods for obtaining populations of norepinephrine (NE) neuronal progenitor cells and creating enriched populations of NE neurons are provided herein. Also provided herein are methods for obtaining g...            
Learn More
        Learn More
            Su-Chun Zhang, Yunlong Tao | P200364US02
        
    Technology
PLASMID ENCODING INFECTIOUS RHINOVIRUS-C GENOTYPE C45
            UW-Madison researchers have cloned, sequenced and characterized the genome from an isolate of the RV-C45 genotype, and they’ve provided the cDNA for a high titer HRV-C (C45-2A-D41K), as well as the ...            
Learn More
        Learn More
            Ann Palmenberg | P210398US01
        
    Technology
RPE CELL LINES WITH PLK4 CONDITIONAL KNOCKOUT AND ANALOG SENSITIVE MUTATION
            UW-Madison researchers have developed two cell lines derived from RPE-1 cells (which were obtained from ATCC), an immortalized, non-transformed human epithelial cell line. “PLK4 WTflox/Delta” is a...            
Learn More
        Learn More
            Mark Burkard, Ryan Denu | P210364US01
        
    Technology
CHO Cell Line Expressing HERG-1 Potassium Channels
            HERG-1 (human ether-a-go-go-related gene) potassium channels mediate repolarization of cardiac action potentials. Loss of function mutations in hERG-1 can result in long QT syndrome, an inherited diso...            
Learn More
        Learn More
            Gail Robertson, Barry Ganetzky, Jeffrey Warmke, Matthew Trudeau, Samuel Breit, Terence Campbell, Bruce Walker, Stella Valenzuela | P00082US
        
    Technology
Rhinovirus-C Peptide for Development of Vaccines and Antivirals
            Human rhinoviruses (species A, B and C) are responsible for the majority of upper respiratory tract infections (like the common cold) and many infections of the lower respiratory tract as well. 
Rhin...            
Learn More
        Learn More
            Ann Palmenberg, Marchel Hill, Kelly Watters, Michael Rossman, Yue Liu | P160341US02
        
    Technology
New Target for Diagnosing, Treating Neurodegenerative Diseases
            Amyotrophic lateral sclerosis (ALS) is a devastating disease with no effective treatment. In patients with ALS, the neurons in their brains degenerate, leading to cognitive and physical breakdown. Oth...            
Learn More
        Learn More
            Su-Chun Zhang, Hong Chen | P140125US02
        
    Technology
Increasing Red Blood Cell Production
            Maintaining an adequate supply of oxygen to tissue is necessary for survival. The oxygen-carrying capacity of blood is governed by the concentration of red blood cells (erythrocytes). It is critical t...            
Learn More
        Learn More
            Emery Bresnick, Yoon A Kang, Skye McIver | P130326US02
        
    Technology
Mouse Strains and Cells Useful to Investigate Tissue-Specific Roles of Stearoyl-CoA Desaturase Isoforms
            Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids. SCDs may influence the development of diseases such as obesity, atherosclerosis and diabet...            
Learn More
        Learn More
            James Ntambi | P08224US
        
    Technology
Method to Screen for Novel Antibiotics
            The antibiotic vancomycin targets the peptidoglycan-containing bacterial cell wall. Inducible resistance to vancomycin and other glycopeptide antibiotics is becoming a serious health problem, necessit...            
Learn More
        Learn More
            Bernard Weisblum, Robert Giannattasio, Arcady Grenader, Andrew Ulijasz, David Kovalic | P96061US
        
    Technology
Stem Cell Marker for Breast Cancer
            In patients who develop breast cancer, malignant tumors frequently begin in somatic mammary stem cells. In addition, breast tumors have a stem cell component that propagates the tumor, which may expla...            
Learn More
        Learn More
            Caroline Alexander, Bart Williams, Charlotta Lindvall, Nisha Badders | P07136US
        
    Technology
Methods and Materials for Assaying Non-SCD1 Isoforms
            Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids. Inhibitors of SCD may be useful therapeutics for diseases such as obesity and diabetes.            
Learn More
        Learn More
            James Ntambi, Makoto Miyazaki | P05362US
        
    Technology
Vaccine Candidates Against Johne's Disease
            Johne’s disease is a contagious, chronic and usually fatal wasting disease that primarily affects the small intestine of ruminants. It is a worldwide problem with no known treatment and infects 25 t...            
Learn More
        Learn More
            Adel Talaat | P05446US